Business · 22/10/20261 min read

Oakworth Capital Inc. Reports 19% Growth in Net Income

Summary

BIRMINGHAM, Ala., Oct. 22, 2026 — Oakworth Capital Inc. (OTCQX: OAKC) reported 19% net income growth and 13% diluted EPS growth in the year-to-date period ended September 30, 2026 compared to the same peak...

Original source language: PR Newswire — Global News ReleasesOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News Central Bank Policy News

Related business signals

Business · 10/22/2026

H.I.G. Capital acquires a majority stake in L4A to support further growth and expansion

MILAN, Oct. 23, 2026 — H.I.G. Capital ("H.I".G"., a leading global alternative investment firm with $75 billion in capital under management, is pleased to announce that one of its...

Read summary →

Business · 10/23/2026

Primis Financial Corp. reports strong results for the third quarter of 2026

Declares Quarterly Cash Dividend of $0.10 Per Share MCLEAN, Va., Oct. 22, 2026 — Primis Financial Corp. (NASDAQ: FRST) ("Primis" or the "Company"), and its wholly owned subsidiary, Primis Bank (the "Bank...

Read summary →

Business · 10/23/2026

NEW YORK CITY Unveils the International Room - NYC's first and only exclusive high-roller gaming destination

The exclusive new space brings private gaming salons, personalized luxury hospitality and around the clock dining to Queens as Resorts World NYC celebrates its 15th anniversary NEW YORK, Oct. 22, 2026 — ...

Read summary →

Business · 10/23/2026

Harbour BioMed receives China NMPA approval for Batoclimab injection (subcutaneous injection) for the treatment of generalized myasthenia gravis

The first NMPA-approved anti-FcRn therapy to complete its full clinical development for gMG patients in China CAMBRIDGE, Mass. , ROTTERDAM, Netherlands and SHANGHAI, Oct. 22, 2026 — Harbour BioMed (the "C...

Read summary →

Business · 10/23/2026

Seatrium and Karpowership sign contract for a series of whale class power conversion and integration projects

SINGAPORE, 23 October 2026 — Seatrium Limited and its strategic partner, floating power leader Karpowership, have strengthened their longstanding collaboration with the award of a contract for the development...

Read summary →

Business · 10/23/2026

ImmVira presents clinical data from three bladder cancer studies at ESMO 2026

SUZHOU, China, Oct. 22, 2026 — ImmVira Group ("ImmVira") today announced that updated clinical data from three bladder cancer studies of its leading oncolytic immunotherapy candidate, MVR-T3011, will be pre...

Read summary →